What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001135121
Total reported value
$202.2M
$202.2M
36 檔
36.4%
As reported in its official Q2 2025 Form 13F filing, Brandywine Managers, LLC's tracked investment portfolio stood at $202.2M with 36 total positions.
During Q2 2025, Brandywine Managers, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACWI | Ishares Msci Acwi ETF | ETF-Other | 37.53% | -1.12% | — | |
| 2 | CRWD | Crowdstrike Holdings Inc - A | Stock-Tech | 16.61% | +4.87% | — | |
| 3 | PATH | Uipath Inc - Class A | Stock-Tech | 12.84% | -1.17% | — | |
| 4 | NVDA | Nvidia CORP | Stock-Tech | 3.19% | -0.44% | — | |
| 5 | NTRA | Natera Inc | Stock-Healthcare | 2.99% | +0.24% | -1.11% | |
| 6 | UBER | Uber Technologies Inc | Stock-Industrials | 2.72% | -0.19% | — | |
| 7 | ZS | Zscaler Inc | Stock-Tech | 2.61% | — | — | |
| 8 | NET | Cloudflare Inc - Class A | Stock-Tech | 1.93% | +0.10% | — | |
| 9 | CRM | Salesforce Inc | Stock-Tech | 1.87% | -0.22% | — | |
| 10 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.72% | -0.26% | -2.00% | |
| 11 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.37% | -0.27% | -2.99% | |
| 12 | DDOG | Datadog Inc - Class A | Stock-Tech | 1.35% | +0.60% | — | |
| 13 | IOT | Samsara Inc-cl A | Stock-Tech | 1.22% | -0.08% | — | |
| 14 | SNOW | Snowflake Inc | Stock-Tech | 1.11% | +0.19% | — | |
| 15 | OKTA | Okta Inc | Stock-Tech | 1.02% | +0.06% | -7.20% | |
| 16 | AMD | Advanced Micro Devices | Stock-Tech | 1.00% | +0.65% | -10.13% | |
| 17 | MA | Mastercard Inc - A | Stock-Financials | 1.00% | -0.07% | — | |
| 18 | NOW | Servicenow Inc | Stock-Tech | 0.91% | — | — | |
| 19 | MDB | Mongodb Inc | Stock-Tech | 0.86% | +0.07% | +17.71% | |
| 20 | VEEV | Veeva Systems Inc-class A | Stock-Healthcare | 0.79% | — | -15.34% | |
| 21 | TWST | Twist Bioscience CORP | Stock-Other | 0.77% | +0.48% | — | |
| 22 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.54% | -0.17% | — | |
| 23 | GH | Guardant Health Inc | Stock-Healthcare | 0.53% | +0.18% | — | |
| 24 | PD | Pagerduty Inc | Stock-Other | 0.46% | +0.04% | — | |
| 25 | KVYO | Klaviyo Inc-a | Stock-Other | 0.44% | -0.07% | +50.00% | |
| 26 | SDGR | Schrodinger Inc | Stock-Other | 0.42% | +0.04% | — | |
| 27 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.31% | +0.07% | +64.57% | |
| 28 | TWLO | Twilio Inc - A | Stock-Tech | 0.29% | +0.07% | — | |
| 29 | MRNA | Moderna Inc | Stock-Healthcare | 0.26% | +0.05% | — | |
| 30 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.26% | — | -11.25% | |
| 31 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.23% | -0.03% | — | |
| 32 | TXG | 10x Genomics Inc-class A | Stock-Other | 0.22% | +0.12% | — | |
| 33 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.21% | — | — | |
| 34 | S | Sentinelone Inc -class A | Stock-Tech | 0.19% | — | -44.73% | |
| 35 | RLAY | Relay Therapeutics Inc | Stock-Other | 0.13% | +0.14% | — | |
| 36 | ABCL | Abcellera Biologics Inc | Stock-Other | 0.10% | +0.05% | — |
According to official SEC Form 13F filings, Brandywine Managers, LLC reported a total U.S. public equity portfolio value of $202.2M across 36 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ACWI, CRWD, PATH) accounted for 36.4% of total reported equity market value during Q2 2025.
During Q2 2025, Brandywine Managers, LLC's top holdings by market value included ACWI (37.5%)、CRWD (16.6%)、PATH (12.8%). The largest single position, ACWI, represented 37.5% of total portfolio value.
In Q2 2025, Brandywine Managers, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.